Who owns Enliven Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ELVN from SEC Form 13F filings across 213 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 213 institutions disclosed 80.2M shares of Enliven Therapeutics, Inc. worth $4.06B — about 121.2% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
213
13F holders
$4.06B
value, 2026 filers
121.2%
of shares outstanding (80.2M sh)
70
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ELVN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 10.0M | $508.8M | 0.0% | 15.2% | +46.8% |
| 2 | ORBIMED ADVISORS LLC | 6.8M | $343.9M | 6.4% | 10.2% | -14.9% |
| 3 | Polar Capital Holdings Plc | 6.4M | $326.4M | 0.8% | 9.7% | +26.9% |
| 4 | BlackRock, Inc. | 4.4M | $221.3M | 0.0% | 6.6% | +18.3% |
| 5 | Vestal Point Capital, LP | 4.0M | $203.0M | 4.7% | 6% | +23.1% |
| 6 | Commodore Capital LP | 3.3M | $166.2M | 9.9% | 4.9% | 0.0% |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.9M | $147.4M | 0.0% | 4.4% | +2870.8% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 2.6M | $130.4M | 0.0% | 3.9% | new |
| 9 | CITADEL ADVISORS LLC | 2.1M | $105.0M | 0.0% | 3.1% | +18.6% |
| 10 | Fairmount Funds Management LLC | 1.9M | $94.2M | 6.2% | 2.8% | 0.0% |
| 11 | Siren, L.L.C. | 1.8M | $90.1M | 1.8% | 2.7% | +137.8% |
| 12 | Bellevue Group AG | 1.5M | $75.6M | 1.6% | 2.3% | -35.8% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $71.4M | 0.0% | 2.1% | +32.0% |
| 14 | First Light Asset Management, LLC | 1.4M | $69.1M | 4.2% | 2.1% | +574.1% |
| 15 | STATE STREET CORP | 1.2M | $61.6M | 0.0% | 1.8% | +11.2% |
| 16 | Pictet Asset Management Holding SA | 1.2M | $59.0M | 0.1% | 1.8% | +25.0% |
| 17 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 1.1M | $55.0M | 0.1% | 1.6% | new |
| 18 | NOVO HOLDINGS A/S | 1.0M | $50.8M | 2.9% | 1.5% | -21.9% |
| 19 | First Turn Management, LLC | 954,360 | $48.4M | 5.2% | 1.4% | +53.0% |
| 20 | SAMLYN CAPITAL, LLCNEW | 912,637 | $46.3M | 0.8% | 1.4% | new |
| 21 | Candriam S.C.A. | 905,674 | $45.9M | 0.2% | 1.4% | +52.5% |
| 22 | BAKER BROS. ADVISORS LP | 905,191 | $45.9M | 0.2% | 1.4% | 0.0% |
| 23 | ALLIANCEBERNSTEIN L.P. | 896,161 | $35.1M | 0.0% | 1.4% | +16.1% |
| 24 | Tri Locum Partners LPNEW | 866,716 | $44.0M | 5.4% | 1.3% | new |
| 25 | DIMENSIONAL FUND ADVISORS LP | 671,412 | $34.1M | 0.0% | 1% | -1.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.